Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by H.-S. Hur
Combination of EGFR and MEK1/2 Inhibitor Shows Synergistic Effects by Suppressing EGFR/HER3-dependent AKT Activation in Human Gastric Cancer Cells
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Feedback Activation of HER3 Attenuates Response to EGFR Inhibitors in Colon Cancer Cells
Oncotarget
Oncology
Emodin Sensitizes Human Pancreatic Cancer Cells to EGFR Inhibitor Through Suppressing Stat3 Signaling Pathway
Cancer Management and Research
Oncology
EZH2 Inhibition Enhances the Efficacy of an EGFR Inhibitor in Suppressing Colon Cancer Cells
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Lapatinib, a Dual EGFR and HER2 Kinase Inhibitor, Selectively Inhibits HER2-Amplified Human Gastric Cancer Cells and Is Synergistic With Trastuzumab in Vitro and in Vivo
Clinical Cancer Research
Cancer Research
Oncology
EGFR Inhibitor C225 Increases the Radio-Sensitivity of Human Breast Cancer Cells
Asian Pacific Journal of Cancer Prevention
ETS1 Mediates MEK1/2-Dependent Overexpression of Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A) in Human Cancer Cells
PLoS ONE
Multidisciplinary
Antagonism of EGFR and HER3 Enhances the Response to Inhibitors of the PI3K-Akt Pathway in Triple-Negative Breast Cancer
Science Signaling
Biochemistry
Cell Biology
Molecular Biology
Gemcitabine Overcomes Erlotinib Resistance in EGFR-Overexpressing Cancer Cells Through Downregulation of Akt
Journal of Cancer
Oncology
Akt Activation by Ca2+/Calmodulin-Dependent Protein Kinase Kinase 2 (CaMKK2) in Ovarian Cancer Cells
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
